| The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical … PI Gonzalez‐Ericsson, ES Stovgaard, LF Sua, E Reisenbichler, Z Kos, ... The Journal of pathology 250 (5), 667-684, 2020 | 193 | 2020 |
| Report on computational assessment of tumor infiltrating lymphocytes from the International Immuno-Oncology Biomarker Working Group M Amgad, ES Stovgaard, E Balslev, J Thagaard, W Chen, S Dudgeon, ... NPJ breast cancer 6 (1), 16, 2020 | 148 | 2020 |
| Malignant peritoneal mesothelioma: a review G Broeckx, P Pauwels Translational lung cancer research 7 (5), 537, 2018 | 96 | 2018 |
| Acute myocarditis associated with desmosomal gene variants E Ammirati, F Raimondi, N Piriou, L Sardo Infirri, SA Mohiddin, A Mazzanti, ... Heart Failure 10 (10), 714-727, 2022 | 85 | 2022 |
| Determination of the Potential Tumor-Suppressive Effects of Gsdme in a Chemically Induced and in a Genetically Modified Intestinal Cancer Mouse Model L Croes, E Fransen, M Hylebos, K Buys, C Hermans, G Broeckx, ... Cancers 11 (8), 1214, 2019 | 39 | 2019 |
| Clinical performance of the Idylla MSI test for a rapid assessment of the DNA microsatellite status in human colorectal cancer K Zwaenepoel, JH Duelund, K De Winne, V Maes, C Weyn, S Lambin, ... The Journal of Molecular Diagnostics 22 (3), 386-395, 2020 | 36 | 2020 |
| Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with … MR Van Bockstal, A François, S Altinay, L Arnould, M Balkenhol, ... Modern pathology 34 (12), 2130-2140, 2021 | 30 | 2021 |
| Mass spectrometry imaging reveals neutrophil defensins as additional biomarkers for anti-PD-(L) 1 immunotherapy response in NSCLC patients E Berghmans, J Jacobs, C Deben, C Hermans, G Broeckx, E Smits, ... Cancers 12 (4), 863, 2020 | 29 | 2020 |
| Pitfalls in machine learning‐based assessment of tumor‐infiltrating lymphocytes in breast cancer: A report of the International Immuno‐Oncology Biomarker Working Group on … J Thagaard, G Broeckx, DB Page, CA Jahangir, S Verbandt, Z Kos, ... The Journal of pathology 260 (5), 498-513, 2023 | 28 | 2023 |
| Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials J Hudeček, L Voorwerk, M van Seijen, I Nederlof, M de Maaker, ... NPJ Breast Cancer 6 (1), 15, 2020 | 25 | 2020 |
| Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno‐Oncology Biomarker Working Group on Breast … DB Page, G Broeckx, CA Jahangir, S Verbandt, RR Gupta, J Thagaard, ... The Journal of pathology 260 (5), 514-532, 2023 | 22 | 2023 |
| Biomarkers of the tumor microenvironment LA Akslen, RS Watnick Springer Nature, 2022 | 22 | 2022 |
| Interobserver variation in the assessment of immunohistochemistry expression levels in HER2-negative breast cancer: can we improve the identification of low levels of HER2 … X Baez-Navarro, MR van Bockstal, D Nawawi, G Broeckx, C Colpaert, ... Modern Pathology 36 (1), 100009, 2023 | 20 | 2023 |
| Next-generation protein analysis in the pathology department M Ahmed, G Broeckx, G Baggerman, K Schildermans, P Pauwels, ... Journal of Clinical Pathology 73 (1), 1-6, 2020 | 20 | 2020 |
| The immunologic aspects in hormone receptor positive breast cancer G Oner, S Altintas, Z Canturk, W Tjalma, C Van Berckelaer, G Broeckx, ... Cancer Treatment and Research Communications 25, 100207, 2020 | 17 | 2020 |
| The evolution and prognostic role of tumour-infiltrating lymphocytes and peripheral blood-based biomarkers in inflammatory breast cancer patients treated with neoadjuvant … C Van Berckelaer, I Vermeiren, L Vercauteren, C Rypens, G Oner, ... Cancers 13 (18), 4656, 2021 | 14 | 2021 |
| Cervicovaginal cellular angiofibroma S Van Mulders, E Faes, G Broeckx, Y Jacquemyn BMJ Case Reports CP 13 (7), e235241, 2020 | 9 | 2020 |
| Validation of liquid biopsy for ESR1-mutation analysis in hormone-sensitive breast cancer: a pooled meta-analysis O Najim, K Papadimitriou, G Broeckx, M Huizing, W Tjalma Frontiers in Oncology 13, 1221773, 2023 | 8 | 2023 |
| International Immuno‐Oncology Biomarker Working Group The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as … PI Gonzalez-Ericsson, ES Stovgaard, LF Sua, E Reisenbichler, Z Kos, ... J Pathol 250 (5), 667-684, 2020 | 8 | 2020 |
| Image‐based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno‐oncology Biomarker Working Group on Breast Cancer CA Jahangir, DB Page, G Broeckx, CA Gonzalez, C Burke, C Murphy, ... The Journal of pathology 262 (3), 271-288, 2024 | 6 | 2024 |
